Time Scale Financial, Inc. Trevena Inc Transaction History

Time Scale Financial, Inc.

  • $462 Million
  • Q2 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 07, 2020
BUY
$1.53 - $3.13 $9,476 - $19,387
6,194 Added 104.07%
12,146 $36,000
Q2 2019

Jul 31, 2019
BUY
$0.94 - $1.6 $5,594 - $9,523
5,952 New
5,952 $6,000

About TREVENA INC

TRVN Quotes by TradingView
  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Time Scale Financial, Inc. Portfolio

Follow Time Scale Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Time Scale Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Time Scale Financial, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email